# Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma

> **NCT06171321** · NA · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 94 (estimated)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **DRUG:** S-1(Intravenous combined with oral)

## Key facts

- **NCT ID:** NCT06171321
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2025-11-15
- **Final completion:** 2026-04-01
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171321, "Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06171321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*